CVS Health Posts Upbeat Earnings, Johnson Controls Mixed Results
- August 02nd, 2023
- 242 views
CVS Health Corporation (NYSE: CVS) announced second quarter 2023 adjusted earnings per share (EPS) of $2.21 and recorded revenues of $88.92 billion, surpassing the consensus EPS estimate of $2.11 on revenues of $86.45 billion.
The company confirmed its full-year 2023 adjusted EPS guidance range of $8.50 to $8.70, aligning closely with analysts' expectations of $8.59.
In pre-market, $CVS was trading at $72.00, down $1.51 (+2.04%).
In a separate development, Johnson Controls International plc (NYSE: JCI) reported third-quarter fiscal 2023 adjusted EPS of $1.03, matching analysts' forecasts. However, quarterly sales were slightly lower than expected at $7.13 billion, compared to the consensus estimate of $7.19 billion in revenue.
For the upcoming quarter, Johnson Controls anticipates Q4 adjusted EPS of $1.10, slightly below the consensus estimate of $1.13 for the period.
$JCI was trading at $65.50 in pre-market, down $4.53 (-6.47%)
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
CSX, VinFast Auto, and Crown Castle's Earnings Preview
April 14th, 2024Earnings Spotlight: McCormick, TD SYNNEX, and GameStop Set to Report
March 23rd, 2024Upcoming Earnings: Adobe, Ulta Beauty, and Smartsheet Under the Lens
March 10th, 2024
Member Login